Interstitial lung disease and Hepatic function abnormal

Summary:

Hepatic function abnormal is found among people with Interstitial lung disease, especially for people who are male, 60+ old.

The study analyzes which people have Hepatic function abnormal with Interstitial lung disease. It is created by eHealthMe based on reports of 140 people who have Interstitial lung disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,501 drugs and 1,839 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,442 drugs and 2,020 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Jul, 02, 2026

140 people who have Interstitial Lung Disease and Hepatic Function Abnormal are studied.

Would you have Hepatic function abnormal when you have Interstitial lung disease?

Gender of people who have Interstitial lung disease and experienced Hepatic function abnormal *:

Click here to view

Age of people who have Interstitial lung disease and experienced Hepatic function abnormal *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition

Related publications that referenced our studies

Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

Related studies:

Treatments, associated drugs and conditions:

Interstitial lung disease (69,101 reports)
Hepatic function abnormal (47,051 reports)

All the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,442 drugs)

All the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,020 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatic function abnormal and Interstitial lung disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.